Johan W. Molling

Peripheral blood IFN‐γ‐secreting Vα24⁺Vβ11⁺ NKT cell numbers are decreased in cancer patients independent of tumor type or tumor load

Johan W. Molling, Wendy Kölgen, Martijn F. Boomsma et al. · International Journal of Cancer · 2005 · 231 citations · Full text

Life Sciences, Immunology, Oncology +17

Low Levels of Circulating Invariant Natural Killer T Cells Predict Poor Clinical Outcome in Patients With Head and Neck Squamous Cell Carcinoma

Johan W. Molling, J.A.E. Langius, Johannes A. Langendijk et al. · Journal of Clinical Oncology · 2007 · 201 citations · Full text

Life Sciences, Immunology, Oncology +7

CD4⁺CD25^hi regulatory T‐cell frequency correlates with persistence of human papillomavirus type 16 and T helper cell responses in patients with cervical intraepithelial neoplasia

Johan W. Molling, Tanja D. de Gruijl, Judith E. Glim et al. · International Journal of Cancer · 2007 · 138 citations · Full text

Medicine, Immunology, Oncology +17

TLR Ligands in the Local Treatment of Established Intracerebral Murine Gliomas

Oliver Grauer, Johan W. Molling, Erik Bennink et al. · The Journal of Immunology · 2008 · 134 citations · Full text

Medicine, Immunology, Oncology +16

Polarization of Valpha24+ Vbeta11+ natural killer T cells of healthy volunteers and cancer patients using alpha-galactosylceramide-loaded and environmentally instructed dendritic cells.

Johan W. Molling, Nobusuke Nishi, Allan J. Masterson et al. · PubMed · 2003 · 68 citations

Life Sciences, Immunology, Oncology +17